Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells

Blood

Volumn 98, Issue 2, 2001, Pages 414-421

  Jia, Li ^a,b   Srinivasula, Srinivasa M ^a,b   Liu, Feng Ting ^a,b   Newland, Adrian C ^a,b   Fernandes Alnemri, Teresa ^a,b   Alnemri, Emad S ^a,b   Kelsey, Stephen M ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9B; CYTOCHROME C; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CELL STRAIN K 562; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN SECRETION; ULTRAVIOLET IRRADIATION;

EID: 0035880232     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.2.414     Document Type: Article

References (34)

1. Liu X, Kim N, Yang J, Jemmerson R, Wang X. Induction of apoptosis program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147-157.
2. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479-489.
3. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1 a human protein homologous to C. elegans CED-4 participates in cytochrome c-dependent activation of caspase-3. Cell. 1997;90:405-413.
4. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell. 1998;1:949-957.
5. Fearnhead HO, Rodriguez J, Govek E-E, et al. Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci U S A. 1998;95:13664-13669.
6. Hu Y, Benedict MA, Ding L, Núñez G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 1999;18:3586-3595.
7. Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature. 1999;399:549-557.
8. Soengas MS, Alarcon RM, Yoshida H, et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 1999;284:156-159.
9. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132-1136.
10. Jia L, Macey MG, Yin Y, Newland AC, Kelsey SM. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood. 1999;93:2353-2359.
11. Cain K, Brown DG, Langlais C, Cohen GM. Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex. J Biol Chem. 1999;274:22686-22692.
12. Adrain C, Slee EA, Harte MT, Martin SJ. Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the WD-40 repeat region. J Biol Chem. 1999;274:20855-20860.
13. Hu Y, Ding L, Spencer DM, Núñez G. WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation. J Biol Chem. 1998;273:33489-33494.
14. Saleh A, Srinivasula SM, Acharya S, Fishel R, Alnemri ES. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem. 1999;274:17941-17945.
15. Yang X, Stennicke HR, Wang B, et al. Granzyme B mimics apical caspases: description of a unified pathway for trans-activation of executioner caspase-3 and -7. J Biol Chem. 1998;273:34278-34283.
16. Hakem R, Hakem A, Duncan GS, et al. Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell. 1998;94:339-352.
17. Kuida K, Haydar TF, Kuan CY, et al. Reduced apoptosis and cytochrome c-mediated caspase-activation in mice lacking caspase-9. Cell. 1998;94:325-337.
18. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf-1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 1998;94:727-737.
19. Yoshida H, Kong YY, Yoshida R, et al. Apaf-1 is required for mitochondrial pathways of apoptosis and brain development. Cell. 1998;94:739-750.
20. Perkins C, Kim CN, Fang G, Bhalla KN. Overexpression Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res. 1998;58:4561-4566.
21. Srinivasula SM, Ahmad M, Guo Y, et al. Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res. 1999;59:999-1002.
22. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998;17:2215-2223.
23. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102:33-42.
24. Srinivasula SM, Datta P, Fan X-J, Fernandes-Alnemri T, Huang Z, Alnemri ES. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem. 2000;275:36152-36157.
25. Jia L, Kelsey SM, Grahn MF, Newland AC. Increased activity and sensitivity of mitochondrial respiratory enzymes to TNF-α-induced inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines. Blood. 1996;87:2401-2410.
26. Jia L, Doumashkin RR, Allen PD, Gray AB, Newland AC, Kelsey SM. Inhibition of autophagy abrogates TNF-α-induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol. 1997a;98:673-685.
27. Jia L, Dourmashkin RR, Newland AC, Kelsey SM. Mitochondrial ultracondensation, but not swelling, is involved in TNF-α-induced apoptosis in human T-lymphoblastic leukaemic cells. Leuk Res. 1997;21:973-983.
28. Kanter PM, Schwartz HS. A fluorescence enhancement assay for cellular DNA damage. Mol Pharmacol. 1982;22:145-151.
29. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129-1132.
30. Vander-Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 1997;91:627-637.
31. Jia L, Allen PD, Macey MG, Grahn MF, Newland AC, Kelsey SM. Mitochondrial electron transport chain activity, but not ATP synthesis, is required for drug-induced apoptosis in human leukaemic cells: a possible novel mechanism of regulating drug resistance. B r J Haematol. 1997b;98:686-698.
32. Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat Med. 1999;5:412-417.
33. Martins LM, Mesner PW, Kottke TJ, et al. Comparison of caspases activation and subcellular localization in HL-60 and K562 cells undergoing etoposicle-induced apoptosis. Blood. 1997;90:4283-4296.
34. Perkins C, Kim CN, Fang G, Bhalla KN. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2 or Bcl-x(L). Blood. 2000;95:1014-1022.